Hematology TimesDrug receives orphan designation for ALLApril 25, 2018Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesGO approved to treat AML in EuropeApril 24, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesExercise linked to risk of death in cancer patientsApril 24, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
Hematology TimesArt education benefits blood cancer patientsApril 23, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingTransplantationAML
Hematology TimesBET inhibitor has lasting effects in AML, MMApril 21, 2018Leukemia, Myelodysplasia, TransplantationMultiple MyelomaAML
Hematology TimesStudy reveals gene variants that predispose kids to ALLApril 20, 2018Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesInhibitor outperforms rivals in leukemia, lymphomaApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesTeam uses iPSCs to create ‘universal’ CAR T cellsApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesGroups launch open portal for cancer modelsApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Hematology TimesAntibody has ‘potent’ effects against AMLApril 19, 2018Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsCheckpoint inhibition after HiDAC shows promise in AMLApril 18, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsVenetoclax shows muscle against CLL relapsed after idelalisibApril 18, 2018CLLIndolent LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsIbrutinib plus carfilzomib active in relapsed multiple myelomaApril 18, 2018Multiple MyelomaLeukemia, Myelodysplasia, Transplantation
Hematology News5- and 10-day decitabine go head-to-head in poor-risk AMLApril 18, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsStatin plus chemo yields encouraging results in poor-risk AMLApril 17, 2018AMLLeukemia, Myelodysplasia, Transplantation
